SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Disability versus Difference over Development in the Autisms

This project aims to develop the AUTISMS-3D model to differentiate autism subtypes based on disability versus difference, enhancing understanding and treatment through data-driven stratification and neurobiological analysis.

Subsidie
€ 1.999.750
2024

Projectdetails

Introduction

Autism is an early developing condition diagnosed on the basis of difficulties in the domains of social-communication and restricted repetitive behaviors. However, the single label of ‘autism’ masks a large degree of heterogeneity at multiple scales, from genome to phenome, and may not signal differential needs and services required for some types of profoundly affected individuals.

Research Goals

In order to better understand autism and develop more impactful ways to facilitate positive outcomes at an individualized level, we need better models that help to explain how autism may be differentiated in meaningful ways. This differentiation can help explain variability in:

  1. Developmental paths
  2. Responses to treatment
  3. Differential underlying neurobiological mechanisms

AUTISMS-3D Model

This research program develops and tests the AUTISMS-3D model – disability versus difference over development - as a first-level major distinction for explaining heterogeneity within the autism population.

Key Postulate

AUTISMS-3D postulates that the major first-level split within the autism population is between subtypes described by:

  • Profound disability
  • Difference in developmental outcomes

Stratification Models

Stratification models using standardized clinical measures of intellectual functioning, language, and adaptive behavior will be used to predict ‘disability’ versus ‘difference’ subtypes. These stratification models are based on highly reproducible data-driven clustering analyses from very large phenotypic datasets.

Developmental Analysis

We will then test how the subtypes may develop differently with analyses of big clinical longitudinal datasets and also within the context of early intervention.

Neurobiological Testing

Finally, we will test the subtypes for neurobiological differences via:

  • Neuroimaging (MRI, fMRI, DTI)
  • Electrophysiological (EEG)
  • Gaze phenotypes (e.g., eye tracking) under static and naturalistic viewing conditions.

Conclusion

The research will help refine our understanding and concepts of autism and will be an important next step on the path to precision medicine for the autisms.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.999.750
Totale projectbegroting€ 1.999.750

Tijdlijn

Startdatum1-1-2024
Einddatum31-12-2028
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIApenvoerder
  • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Land(en)

ItalyUnited States

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Toward an understanding of the brain interstitial system and the extracellular proteome in health and autism spectrum disorders

This project aims to investigate the role of extracellular proteins in brain development and autism spectrum disorders using advanced techniques to identify and analyze their effects.

ERC Consolid...€ 1.997.729
2022
Details

Subtype as a key to reduce heterogeneity of treatment effects in major depressive disorder

SUBTREAT aims to enhance treatment for major depressive disorder by identifying subtypes through advanced data science, exploring their causes, and developing predictive algorithms for tailored therapies.

ERC Starting...€ 1.500.000
2022
Details

Deciphering Alzheimer’s disease molecular subtypes to advance treatment development.

This project aims to identify Alzheimer's disease subtypes through CSF proteomics to develop tailored treatments and theragnostic tools linked to cognitive decline and genetic factors.

ERC Consolid...€ 2.999.934
2025
Details

COgnitive Dynamics in Early Childhood

This project aims to investigate the short-term variability in cognitive performance among children and its impact on long-term outcomes, using advanced measurement techniques over three years.

ERC Starting...€ 1.500.000
2023
Details

Enhancing Synchrony in Autism: Introducing the MirrorPods-Intervention Platform

AUTISMsync develops MirrorPods, an innovative intervention platform using technology and human interaction to enhance temporal synchrony in autistic child-parent dyads, aiming to improve behavioral therapies.

ERC Proof of...€ 150.000
2025
Details
ERC Consolid...

Toward an understanding of the brain interstitial system and the extracellular proteome in health and autism spectrum disorders

This project aims to investigate the role of extracellular proteins in brain development and autism spectrum disorders using advanced techniques to identify and analyze their effects.

ERC Consolidator Grant
€ 1.997.729
2022
Details
ERC Starting...

Subtype as a key to reduce heterogeneity of treatment effects in major depressive disorder

SUBTREAT aims to enhance treatment for major depressive disorder by identifying subtypes through advanced data science, exploring their causes, and developing predictive algorithms for tailored therapies.

ERC Starting Grant
€ 1.500.000
2022
Details
ERC Consolid...

Deciphering Alzheimer’s disease molecular subtypes to advance treatment development.

This project aims to identify Alzheimer's disease subtypes through CSF proteomics to develop tailored treatments and theragnostic tools linked to cognitive decline and genetic factors.

ERC Consolidator Grant
€ 2.999.934
2025
Details
ERC Starting...

COgnitive Dynamics in Early Childhood

This project aims to investigate the short-term variability in cognitive performance among children and its impact on long-term outcomes, using advanced measurement techniques over three years.

ERC Starting Grant
€ 1.500.000
2023
Details
ERC Proof of...

Enhancing Synchrony in Autism: Introducing the MirrorPods-Intervention Platform

AUTISMsync develops MirrorPods, an innovative intervention platform using technology and human interaction to enhance temporal synchrony in autistic child-parent dyads, aiming to improve behavioral therapies.

ERC Proof of Concept
€ 150.000
2025
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

MultiomIcs based Risk stratification of Atherosclerotic CardiovascuLar disEase

The MIRACLE project aims to develop advanced multiomics-based risk prediction models for atherosclerotic cardiovascular disease by integrating genetic data and biomarkers for improved early diagnosis and treatment.

EIC Pathfinder€ 4.000.000
2023
Details

S4E-platform: Simulaties en Signaaldetectie voor Epilepsie

Het project ontwikkelt een AI-platform (S4E) voor het voorspellen van epilepsiesubtypes via hersensimulaties en fNIRS, om diagnostiek en behandeling te verbeteren.

Mkb-innovati...€ 331.450
2023
Details
EIC Pathfinder

MultiomIcs based Risk stratification of Atherosclerotic CardiovascuLar disEase

The MIRACLE project aims to develop advanced multiomics-based risk prediction models for atherosclerotic cardiovascular disease by integrating genetic data and biomarkers for improved early diagnosis and treatment.

EIC Pathfinder
€ 4.000.000
2023
Details
Mkb-innovati...

S4E-platform: Simulaties en Signaaldetectie voor Epilepsie

Het project ontwikkelt een AI-platform (S4E) voor het voorspellen van epilepsiesubtypes via hersensimulaties en fNIRS, om diagnostiek en behandeling te verbeteren.

Mkb-innovatiestimulering Topsectoren R&D AI
€ 331.450
2023
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.